Frontiers in Genetics,
Journal Year:
2022,
Volume and Issue:
13
Published: June 3, 2022
The
host
epigenetic
landscape
rapidly
changes
during
SARS-CoV-2
infection,
and
evidence
suggest
that
severe
COVID-19
is
associated
with
durable
scars
to
the
epigenome.
Specifically,
aberrant
DNA
methylation
in
immune
cells
alterations
clocks
blood
relate
COVID-19.
However,
a
longitudinal
assessment
of
states
from
healthy
individuals
prior
following
test-confirmed
non-hospitalized
has
not
been
performed.
Moreover,
impact
mRNA
vaccines
upon
epigenome
remains
understudied.
Here,
we
first
examined
21
participants
diagnosis
at
median
time
frame
8.35
weeks;
756
CpGs
were
identified
as
differentially
methylated
an
FDR
adjusted
p
-value
<
0.05.
These
enriched
gene
body,
northern
southern
shelf
regions
genes
involved
metabolic
pathways.
Integrative
analysis
revealed
overlap
among
transcriptional
infection
datasets.
Principal
component-based
clock
estimates
PhenoAge
GrimAge
significantly
increased
people
over
50
by
average
2.1
0.84
years.
In
contrast,
PCPhenoAge
decreased
fewer
than
2.06
This
observed
divergence
was
related
age
cell-type
compositional
CD4
+
T
cells,
B
granulocytes,
plasmablasts,
exhausted
naïve
cells.
Complementary
analyses
36
Pfizer
Moderna
mRNA-based
vaccination
reduced
principal
Horvath
3.91
years
for
those
who
received
Moderna.
reduction
chronological
plasmablasts
pre-
post-vaccination.
findings
potential
utility
biomarker
vaccine
responses.
Future
research
will
need
unravel
significance
durability
short-term
exposure
vaccination.
Metabolism,
Journal Year:
2022,
Volume and Issue:
133, P. 155223 - 155223
Published: May 29, 2022
Metformin
was
first
used
to
treat
type
2
diabetes
in
the
late
1950s
and
2022
remains
first-choice
drug
daily
by
approximately
150
million
people.
An
accumulation
of
positive
pre-clinical
clinical
data
has
stimulated
interest
re-purposing
metformin
a
variety
diseases
including
COVID-19.
In
polycystic
ovary
syndrome
improves
insulin
sensitivity.
1
may
help
reduce
dose.
Meta-analysis
from
studies
link
reduction
incidence
cancer.
Clinical
trials,
MILES
(Metformin
Longevity
Study),
TAME
(Targeting
Aging
with
Metformin),
have
been
designed
determine
if
can
offset
aging
extend
lifespan.
Pre-clinical
suggest
that
metformin,
via
suppression
pro-inflammatory
pathways,
protection
mitochondria
vascular
function,
direct
actions
on
neuronal
stem
cells,
protect
against
neurodegenerative
diseases.
also
studied
for
its
anti-bacterial,
-viral,
-malaria
efficacy.
Collectively,
these
raise
question:
Is
all
diseases?
It
unclear
as
whether
putative
beneficial
effects
are
secondary
an
anti-hyperglycemic
insulin-sensitizing
drug,
or
result
other
cellular
actions,
inhibition
mTOR
(mammalian
target
rapamycin),
anti-viral
actions.
Clarification
is
sought
ex
vivo
based
use
high
concentrations
be
translated
into
benefits,
they
reflect
'Paracelsus'
effect.
The
environmental
impact
no
known
metabolites,
another
emerging
issue
linked
endocrine
disruption
fish,
extensive
T2D
raised
concerns
over
human
reproduction.
objectives
this
review
to:
1)
evaluate
mechanism(s)
action
metformin;
2)
analyze
controversial
evidence
metformin's
effectiveness
treatment
than
diabetes;
3)
assess
reproducibility
data,
finally
4)
reach
informed
conclusion
reasons.
We
conclude
primary
benefits
antihyperglycaemic
secondarily
contribute
reduced
risk
number
thereby
enhancing
healthspan.
However,
like
improving
endothelial
function
independent
glucose
homeostasis
add
therapeutic
Science Translational Medicine,
Journal Year:
2022,
Volume and Issue:
14(674)
Published: Sept. 22, 2022
Obesity,
characterized
by
chronic
low-grade
inflammation
of
the
adipose
tissue,
is
associated
with
adverse
coronavirus
disease
2019
(COVID-19)
outcomes,
yet
underlying
mechanism
unknown.
To
explore
whether
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
infection
tissue
contributes
to
pathogenesis,
we
evaluated
COVID-19
autopsy
cases
and
deeply
profiled
response
SARS-CoV-2
in
vitro.
In
cases,
identified
RNA
adipocytes
an
inflammatory
infiltrate.
We
two
distinct
cellular
targets
infection:
a
subset
tissue-resident
macrophages.
Mature
were
permissive
infection;
although
macrophages
abortively
infected,
initiated
responses
within
both
infected
bystander
preadipocytes.
These
data
suggest
that
could
contribute
severity
through
replication
virus
induction
local
systemic
driven
Cell,
Journal Year:
2023,
Volume and Issue:
186(5), P. 906 - 922
Published: Feb. 2, 2023
ACE2
is
the
indispensable
entry
receptor
for
SARS-CoV
and
SARS-CoV-2.
Because
of
COVID-19
pandemic,
it
has
become
one
most
therapeutically
targeted
human
molecules
in
biomedicine.
serves
two
fundamental
physiological
roles:
as
an
enzyme,
alters
peptide
cascade
balance;
a
chaperone,
controls
intestinal
amino
acid
uptake.
ACE2's
tissue
distribution,
affected
by
co-morbidities
sex,
explains
broad
tropism
coronaviruses
clinical
manifestations
SARS
COVID-19.
ACE2-based
therapeutics
provide
universal
strategy
to
prevent
treat
SARS-CoV-2
infections,
applicable
all
variants
other
emerging
zoonotic
exploiting
their
cellular
receptor.
The
SARS-CoV-2
pandemic
continues
to
rage
around
the
world.
At
same
time,
despite
strong
public
health
measures
and
high
vaccination
rates
in
some
countries,
a
post-COVID-19
syndrome
has
emerged
which
lacks
clear
definition,
prevalence,
or
etiology.
However,
fatigue,
dyspnea,
brain
fog,
lack
of
smell
and/or
taste
are
often
characteristic
patients
with
this
syndrome.
These
evident
more
than
month
after
infection,
labeled
as
Post-Acute
Sequelae
CoV-2
(PASC)
commonly
referred
long-COVID.
Metabolic
dysfunction
(i.e.,
obesity,
insulin
resistance,
diabetes
mellitus)
is
predisposing
risk
factor
for
severe
acute
COVID-19,
there
emerging
evidence
that
plus
chronic
inflammatory
state
may
predispose
PASC.
In
article,
we
explore
potential
pathogenic
metabolic
mechanisms
could
underly
both
COVID-19
PASC,
then
consider
how
these
might
be
targeted
future
therapeutic
approaches.
Diabetes,
Journal Year:
2024,
Volume and Issue:
73(2), P. 169 - 177
Published: Jan. 19, 2024
Excessive
adiposity
in
obesity
is
a
significant
risk
factor
for
development
of
type
2
diabetes
(T2D),
nonalcoholic
fatty
liver
disease,
and
other
cardiometabolic
diseases.
An
unhealthy
expansion
adipose
tissue
(AT)
results
reduced
adipogenesis,
increased
adipocyte
hypertrophy,
hypoxia,
chronic
low-grade
inflammation,
macrophage
infiltration,
insulin
resistance.
This
ultimately
culminates
AT
dysfunction
characterized
by
decreased
secretion
antidiabetic
adipokines
such
as
adiponectin
adipsin
proinflammatory
prodiabetic
including
RBP4
resistin.
imbalance
adipokine
alters
the
physiological
state
communication
with
target
organs
pancreatic
β-cells,
heart,
liver.
In
are
known
to
have
direct
effect
on
secretion,
gene
expression,
cell
death,
and/or
dedifferentiation.
For
instance,
impaired
adipsin,
which
promotes
β-cell
identity,
failure
T2D,
thus
presenting
potential
druggable
improve
preserve
function.
The
cardiac
affected
both
classic
white
AT–secreted
newly
recognized
brown
(BAT)-secreted
BATokines
or
lipokines
that
alter
lipid
deposition
ventricular
liver,
affect
hepatic
gluconeogenesis,
accumulation,
sensitivity,
underscoring
importance
adipose-liver
pathogenesis
disease.
this
perspective,
we
outline
what
currently
about
effects
individual
heart.
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(2), P. 378 - 378
Published: Jan. 9, 2025
Long
COVID,
also
known
as
post-acute
sequelae
of
SARS-CoV-2
infection
(PASC),
is
increasingly
recognized
a
condition
affecting
not
only
adults
but
children
and
adolescents.
While
often
experience
milder
acute
COVID-19
symptoms
compared
to
adults,
some
develop
persistent
physical,
psychological,
neurological
lasting
for
weeks
or
months
after
initial
infection.
The
most
commonly
reported
include
debilitating
fatigue,
respiratory
issues,
headaches,
muscle
pain,
gastrointestinal
disturbances,
cognitive
difficulties,
which
significantly
impact
daily
activities,
schooling,
social
interactions.
Additionally,
many
with
long
COVID
psychological
symptoms,
such
anxiety,
depression,
mood
swings,
irritability,
likely
exacerbated
by
prolonged
illness
lifestyle
disruptions.
Risk
factors
in
pre-existing
health
conditions
asthma,
obesity,
disorders,
adolescents
females
seemingly
more
affected.
Hypothesized
mechanisms
underlying
chronic
immune
dysregulation,
viral
particles
stimulating
inflammation,
autonomic
nervous
system
dysfunction,
mitochondrial
impairment,
may
collectively
contribute
the
variety
observed
symptoms.
Long-term
outcomes
remain
uncertain;
however,
can
lead
school
absenteeism,
withdrawal,
distress,
potentially
development.
Severe
cases
postural
orthostatic
tachycardia
syndrome
(POTS)
reduced
exercise
tolerance.
This
review
synthesizes
existing
literature
on
children,
examining
its
prevalence,
symptomatology,
risk
factors,
potential
mechanisms,
an
emphasis
need
further
clinical
studies.
research
largely
relies
surveys
self-reported
data,
assessments
are
essential
accurately
characterize
pediatric
populations
guide
effective
management
strategies.
Signal Transduction and Targeted Therapy,
Journal Year:
2021,
Volume and Issue:
6(1)
Published: Dec. 16, 2021
Abstract
Abnormal
glucose
and
lipid
metabolism
in
COVID-19
patients
were
recently
reported
with
unclear
mechanism.
In
this
study,
we
retrospectively
investigated
a
cohort
of
without
pre-existing
metabolic-related
diseases,
found
new-onset
insulin
resistance,
hyperglycemia,
decreased
HDL-C
these
patients.
Mechanistically,
SARS-CoV-2
infection
increased
the
expression
RE1-silencing
transcription
factor
(REST),
which
modulated
secreted
metabolic
factors
including
myeloperoxidase,
apelin,
myostatin
at
transcriptional
level,
resulting
perturbation
metabolism.
Furthermore,
several
lipids,
(±)5-HETE,
(±)12-HETE,
propionic
acid,
isobutyric
acid
identified
as
potential
biomarkers
COVID-19-induced
dysregulation,
especially
resistance.
Taken
together,
our
study
revealed
resistance
direct
cause
hyperglycemia
upon
COVID-19,
further
illustrated
underlying
mechanisms,
providing
therapeutic
targets
for
complications.